Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016 Report Now Available on Reports
GlobalData’s pharmaceutical report offering, “Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global herpes simplex market. The report identifies the key trends shaping and driving the global herpes simplex market.
[USPRwire, Tue May 11 2010] DALLAS
ReportsandReports Announce it Will Carry the Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016 Market Research Report in its Store.
Browse the complete Report on: http://www.reportsandreports.com/market-reports/herpes-simplex-drug-pipeline-analysis-and-market-forecasts-to-2/
GlobalData’s pharmaceutical report offering, “Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global herpes simplex market. The report identifies the key trends shaping and driving the global herpes simplex market. The report also provides insight into the prevalent competitive landscape and the emerging players expected to bring significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight into the pipeline products within the global herpes simplex therapeutics sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
GlobalData finds that the global herpes simplex market was worth approximately $2.9 billion in 2009. The global herpes simplex therapeutics market is expected to grow at a CAGR of 11.1% between 2009 and 2016. The primary factor contributing to the increase in revenues over the forecast period is the increase in disease incidence. Presently the therapeutic regimen for Herpes Simplex is dominated by a range of DNA polymerase inhibitors which include Zovirax, Famvir, Valtrex, Denavir and OTC products such as Abreva and Aviralex. This market is a significantly genericized market with many brands across the major seven geographies.
Scope
- Annualized global herpes simplex market revenues data from 2001 to 2009, forecast forward for seven years to 2016.
- Key geographies covered in this report include the US (United States), the UK (united Kingdom), Italy, Spain, Germany, France and Japan.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include DNA polymerase inhibitors, Helicase-primase inhibitors, NFkB regulators, HSV-2 gene and nectin-1 receptor targetters, viral maturation inhibitors and PDI inhibitors.
- Analysis of the current and future market competition in the global herpes simplex market. Key market players covered are BioAlliance Pharma, Nutra Pharma Corporation and AiCuris GmbH & Co. KG.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the future market associated with herpes simplex therapeutics.
Reasons to buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global herpes simplex market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global herpes simplex market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain the competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global herpes simplex market landscape? – Identify, understand and capitalize.
Table of Content
1 Table of contents 3
1.1 List of Tables 4
1.2 List of Figures 4
2 Herpes Simplex Therapeutics Market: Market Characterization 5
2.1 Overview 5
2.2 Herpes Simplex Therapeutics Market Size 5
2.3 Herpes Simplex Therapeutics Market Forecast and CAGR 6
2.4 Drivers and Barriers for the Herpes Simplex Therapeutics Market 7
2.4.1 Drivers for the Herpes Simplex Therapeutics Market 7
2.4.2 Barriers for the Herpes Simplex Therapeutics Market 8
2.5 Opportunity and Unmet Need 8
2.6 Key Takeaway 9
About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.
